دورية أكاديمية
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial
| العنوان: | Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial |
|---|---|
| المؤلفون: | Matulonis, Ursula A., Walder, Lydia, Nøttrup, Trine J, Bessette, Paul, Mahner, Sven, Gil-Martin, Marta, Kalbacher, Elsa, Ledermann, Jonathan A, Wenham, Robert M, Woie, Kathrine, Lau, Susie, Marmé, Frederik, Casado Herraez, Antonio, Hardy-Bessard, Anne-Claire, Banerjee, Susana, Lindahl, Gabriel, Benigno, Benedict, Buscema, Joseph, Travers, Karin, Guy, Holly, Mirza, Mansoor R. |
| بيانات النشر: | Linköpings universitet, Avdelningen för Kirurgi, Ortopedi och Onkologi Linköpings universitet, Medicinska fakulteten Region Östergötland, Onkologiska kliniken US Dana-Farber Cancer Institute, Boston, USA FIECON, Ltd, St Albans, United Kingdom Nordic Society of Gynaecological Oncology; Copenhagen University Hospital, Copenhagen, Denmark PMHC and University of Sherbrooke, Canada Arbeitsgemeinschaft Gynäkologische Onkologie and University of Munich, Munich, Germany Grupo Español de Investigación en Cáncer de Ovario and Institut Català dOncologia-IDIBELL, LHospitalet, Barcelona, Spain Groupe dInvestigateurs Nationaux pour lEtude des Cancers Ovariens and University Hospital Besançon, Besançon, France National Cancer Research Institute, London, United Kingdom; University College London Cancer Institute, London, United Kingdom H. Lee Moffitt Cancer Center, Tampa, USA Nordic Society of Gynaecological Oncology; Haukeland University Hospital, Bergen, Norway PMHC and Jewish General Hospital, Montreal, Québec, Canada Arbeitsgemeinschaft Gynäkologische Onkologie and Universitätsklinikum Heidelberg, Heidelberg, Germany Grupo Español de Investigación en Cáncer de Ovario and Hospital Universitario San Carlos, Madrid, Spain Groupe dInvestigateurs Nationaux pour lEtude des Cancers Ovariens and Centre Amoricain DOncologie, Paris, France National Cancer Research Institute, London, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom; Institute of Cancer Research, London, United Kingdom Nordic Society of Gynaecological Oncology, Sweden Northside Hospital, Atlanta, GA, USA Arizona Oncology, Tucson, AZ, USA TESARO A GSK Company, Waltham, MA, USA American Society of Clinical Oncology |
| سنة النشر: | 2019 |
| المجموعة: | Linköping University Electronic Press (LiU E-Press) |
| مصطلحات موضوعية: | Cancer and Oncology, Cancer och onkologi |
| الوصف: | This study estimated time without symptoms or toxicity (TWiST) with niraparib compared with routine surveillance (RS) in the maintenance treatment of patients with recurrent ovarian cancer. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | Journal of Clinical Oncology, 0732-183X, 2019, 37:34, s. 3183-3191; http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-164843Test; PMID 31518175; ISI:000510836300004 |
| DOI: | 10.1200/JCO.19.00917 |
| الإتاحة: | https://doi.org/10.1200/JCO.19.00917Test http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-164843Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.7D4F636C |
| قاعدة البيانات: | BASE |
| DOI: | 10.1200/JCO.19.00917 |
|---|